Dendritic cells (DCs) and cytokine-induced killer (CIK) cells have both shown activity as immunotherapy in some malignancies. Our aim was to prospective assess the effect of this immunotherapy in patients with stage IV breast cancer.
This research indicates that the combination of DC vaccine and CIK therapy can significantly improve DFS and OS in patients with stage IV breast cancer who only rely on chemother- apy. There is no doubt that DC CIK is a boon to stage IV breast cancer patients.
Article Reference link: click here
Scientific article publishing date : 24/1/2017
Immucura identifier : BSC21_008EN